Obesity
Obesity is a medical condition characterized by excessive body fat accumulation, defined by a BMI over 30 kg/m², that significantly increases the risk of various health issues like cardiovascular diseases, type 2 diabetes, and certain types of cancer. Treatment typically involves reducing calorie intake to create a negative calorie balance.
Health Outcomes
- Absence of Serious Adverse Events
- Acceptability of Cheese Products
- Achieved Normal Weight Gain
- Activation of G-Protein Coupled Receptors
- Alleviated Intestinal Metabolic Disorders
- Alleviated Non-Alcoholic Fatty Liver Disease
- Altered Bifidobacterium Profile
- Altered Circulating Metabolic Profile
- Altered Dominant Microbial Community
- Altered Fatty Acid Profile in Offspring
- Altered Fatty Acid Profiles
- Altered Hormonal Status Regarding Satiety
- Altered Metabolic Profile
- Altered Metabolite Profile
- Altered Microbial Composition
- Altered Microbial Phyla Abundance
- Altered Serum IL-6 Levels
- Altered Short-Chain Fatty Acid Production
- Association with Sarcopenia
- Atherogenic Lipid Profile
- Balanced Gut Microbiota
- Change in Body Weight
- Change in Waist-to-Hip Ratio
- Changed Anthropometric Measure
- Changed Leukocyte Telomere Length
- Changed Maternal Plasma Fatty Acids
- Changes in Health Status from Probiotic Intervention
- Changes in Inflammatory Markers
- Characterized Carbohydrate Metabolism Enzyme Activity
- Comparable Growth with Breastfed Infants
- Decreased Glycocholic Acid Levels in Older Women
- Decreased HDL Cholesterol Level
- Decreased Hafnia-Obesumbacterium Genus
- Decreased Prevotella Copri Relative Abundance
- Decreased Roseburia faecis Relative Abundance
- Decreased Uncarboxylated to Total Osteocalcin Ratio
- Degraded Non-Digestible Carbohydrates
- Disease Prevention
- Disrupted Energy Homeostasis
- Distinct Metabolic Profile
- Elevated Blood Cytokine Levels
- Elevated Fecal Cholesterol Levels
- Elevated IL-6 Levels
- Elevated Insulin Levels
- Elevated Malondialdehyde Levels
- Elevated Plasma Glycerol Levels
- Elevated Plasma-Branched Chain Amino Acids
- Elevated Serum Leptin Levels
- Elevated Serum Lipoprotein Lipase Levels in Gilts
- Elevated Serum TNF-α Levels
- Elevated Short Chain Fatty Acids (SCFAs) Levels
- Elevated Triglyceride Levels
- Endothelial Cell Damage
- Enhanced AMPK Activation
- Enhanced Antioxidant Capacity
- Enhanced Beneficial Gut Microbiota
- Enhanced Diversity of Protective Bifidobacterial Populations
- Enhanced Endoplasmic Reticulum Stress Response
- Enhanced Fatty Acid Metabolism
- Enhanced GLP-1 Response
- Enhanced GLP-1 Secretion
- Enhanced Growth
- Enhanced Growth of Beneficial Gut Bacteria
- Enhanced Gut Microbiota
- Enhanced Health Promotion in Disease Management
- Enhanced Lipid Metabolism in Adipose Tissue
- Enhanced Metabolic Function
- Enhanced Metabolic Pathway Activation
- Enhanced Metabolic Pathway Function
- Enhanced Metabolic Processing of Dietary Molecules
- Enhanced Metabolism of Organic Matter
- Enhanced Metabolite Levels
- Enhanced Polyphenol Levels
- Enhanced SCFA Production
- Enhanced Sport Performance
- Enhanced TGR5 Signaling
- Enhanced Thermogenesis in White Adipose Tissue
- Enhanced Wound Healing
- Extended Lifespan
- Formation of Bifidobacteria Predominant Microbiota
- Improved 5000 m Running Time
- Improved Acceptability of Dairy Products
- Improved Adipocyte Inflammatory Profile
- Improved Adipokine Profile
- Improved Adipose Browning
- Improved Adiposity Biomarkers
- Improved Aerobic Capacity
- Improved Aerobic Endurance Performance
- Improved Aerobic Power
- Improved Anaerobic Power
- Improved Anthropometric Index
- Improved Anthropometric Measures
- Improved Antioxidant Capacity
- Improved Antioxidant Defense
- Improved Antioxidant Function
- Improved Antioxidant Levels
- Improved Antioxidative Response
- Improved ApoB-100/ApoA-1 Ratio
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Athletic Performance
- Improved Bioactivity
- Improved Biochemical Parameters
- Improved Blood Biochemical Indicators
- Improved Blood Biochemical Markers
- Improved Blood Biochemistry
- Improved Blood Clinical Chemistry
- Improved Blood Lipid Profile
- Improved Blood Parameters
- Improved Body Composition
- Improved Body Condition Score
- Improved Body Mass Index
- Improved Body Weight
- Improved Carbohydrate Metabolism
- Improved Carbohydrate Oxidation
- Improved Cardiometabolic Health
- Improved Cholesterol Metabolism
- Improved Cholesterol Profile
- Improved Cholesterol Regulation
- Improved Circadian-Metabolic Function
- Improved Clinical Pregnancy
- Improved Colonic Microbial Diversity
- Improved Consumer Acceptability
- Improved Consumer Acceptance
- Improved Cycling Time Trial Performance
- Improved Dietary Acceptability
- Improved Dietary Component Retention
- Improved Diversity of Gut Microbiota
- Improved Dyslipidemia
- Improved Eating Behaviors
- Improved Egg Mass
- Improved Energy Metabolism
- Improved Energy Metabolism in White Adipose Tissue
- Improved Energy Utilization
- Improved Erectile Function
- Improved Estimated VO2max
- Improved Exercise Performance
- Improved FGF21 Sensitivity
- Improved Fat Metabolism Regulation
- Improved Fatty Acid Oxidation
- Improved Fatty Acid Profile
- Improved Fish Chemical Composition
- Improved Fitness in Breastfed Infants
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Free Radical Scavenging Activity
- Improved Functional Properties of Food
- Improved Gastroesophageal Reflux Symptoms
- Improved Gastrointestinal Hormone Regulation
- Improved General Activity
- Improved General Health
- Improved Glucose Homeostasis
- Improved Glucose Metabolism
- Improved Glucose Response
- Improved Glucose Tolerance
- Improved Glycerophospholipid Metabolism
- Improved Growth Metrics Stability
- Improved Gut Microbial Alpha Diversity
- Improved Gut Microbial Richness
- Improved Gut Microbiome Function
- Improved Gut Microbiome Health
- Improved Gut Microbiota
- Improved Gut Microbiota Diversity
- Improved Gut Microbiota-Related Pathways
- Improved HOMA Index
- Improved Health Condition
- Improved Health Markers
- Improved Health Outcomes
- Improved Health Perception
- Improved Health Promotion
- Improved Health Status
- Improved Health Status Score
- Improved Health-related Quality of Life
- Improved Hepatic Insulin Sensitivity
- Improved High-Intensity Intermittent Exercise Performance
- Improved Homeostasis
- Improved Human Health
- Improved Immune Response to Influenza A
- Improved Incretin Release
- Improved Inflammatory Biomarkers
- Improved Inflammatory Marker Profile
- Improved Inflammatory Profile
- Improved Insulin Levels
- Improved Insulin Resistance
- Improved Insulin Sensitivity
- Improved Intestinal Microbial Composition
- Improved LDL Cholesterol
- Improved Lactate Threshold
- Improved Leptin Secretion
- Improved Lifespan
- Improved Lipid Levels
- Improved Lipid Metabolism
- Improved Lipid Profile
- Improved Lipid Serum Homeostasis
- Improved Longevity
- Improved Lower Body Endurance
- Improved Lower-Body Muscular Strength
- Improved Maternal Metabolic Health
- Improved Maximal Exercise Capacity
- Improved Maximal Oxygen Capacity
- Improved Maximal Oxygen Uptake
- Improved Maximal Walking Performance
- Improved Metabolic Activity of Bacillus coagulans
- Improved Metabolic Disease Markers
- Improved Metabolic Disorders
- Improved Metabolic Function
- Improved Metabolic Health
- Improved Metabolic Homeostasis
- Improved Metabolic Parameters
- Improved Metabolic Pathway Functions in Intestinal Microbiota
- Improved Metabolic Profile
- Improved Metabolic Regulation
- Improved Metabolic Syndrome Biomarkers
- Improved Metabolic Syndrome Remission
- Improved Metabolism
- Improved Metabolism of Host-Derived Glycans
- Improved Metabolome Profile
- Improved Microbial Community Composition
- Improved Microbial Diversity
- Improved Microbial Metabolism Regulation
- Improved Microbiota Profile
- Improved Microflora Composition
- Improved Monocyte Activation
- Improved Motivation to Move
- Improved Muscular Endurance
- Improved NAFLD
- Improved Nutritional Content
- Improved Nutritional Metabolism
- Improved Nutritional Quality
- Improved Nutritional Status
- Improved Overall Health
- Improved Overall Health Status
- Improved Oxidative Metabolism Regulation
- Improved Oxidative Status
- Improved Oxidative Stress Biomarker
- Improved Oxidative Stress Levels
- Improved Oxidative Stress Marker
- Improved Peak Anaerobic Power
- Improved Perceived Physical Health
- Improved Physical Performance
- Improved Physical Quality of Life
- Improved Physical Role Limitation
- Improved Physical Well-being
- Improved Physiological Parameters
- Improved Plasma Antioxidant Levels
- Improved Plasma Lipid Levels
- Improved Post-Myocardial Infarction Outcome
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Proportion of Healthy Days
- Improved Reactive Hyperemia Index
- Improved Redox Homeostasis
- Improved Satiety
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Satiety Response
- Improved Semen Quality
- Improved Serum Antioxidant Capacity
- Improved Serum Averages
- Improved Serum Biochemistry
- Improved Serum Biomarkers
- Improved Serum Lipids
- Improved Serum Parameters
- Improved Serum SOD Activity
- Improved Sprint Performance
- Improved Starch Digestibility
- Improved Stress-Strain Index
- Improved Superoxide Dismutase Level
- Improved Swimming Performance
- Improved Systemic Health
- Improved Systemic Metabolism
- Improved Thermogenesis
- Improved Thermotolerance
- Improved Tolerance
- Improved Total Antioxidant Capacity
- Improved Total Antioxidant Status
- Improved Total Antioxidative Status
- Improved Total Cholesterol Levels
- Improved Triglyceride Levels
- Improved VLDL Cholesterol
- Improved VO2 Max
- Improved VO2max
- Improved Vertical Jump Performance
- Improved Waist-to-Hip Ratio
- Improved Weight Control
- Improved Weight Loss
- Improved Weight Management
- Improved Work Capacity
- Improved Yo-Yo Test Performance
- Increase in Beneficial Bifidobacterial Species
- Increased AMPK Activation
- Increased Abundance of Beneficial Gut Genera
- Increased Abundance of Microbial Fibrolytic Enzymes
- Increased Acyl/Des-Acyl Ghrelin Ratio
- Increased Adipogenesis
- Increased Adiponectin Levels
- Increased Adipose Browning
- Increased Antioxidant Capacity
- Increased Appendicular Lean Mass
- Increased Appetite
- Increased Average Daily Gain During Finisher Period
- Increased Bacteroides ovatus Abundance
- Increased Beneficial Bacterial Species
- Increased Beneficial Gut Bacteria
- Increased Beneficial Gut Microbiota
- Increased Bifidobacteria Growth
- Increased Bifidobacteria Levels in Gut Microbiota
- Increased Bifidobacteria in Fecal Microbiota
- Increased Bifidobacteriaceae Abundance
- Increased Bifidobacterial Counts
- Increased Bifidobacterial Population
- Increased Bifidobacterium Breve Count in Stool
- Increased Bifidobacterium Diversity
- Increased Bifidobacterium adolescentis Levels
- Increased Bifidobacterium longum Relative Abundance
- Increased Bioactivity
- Increased Bioavailability of Phenolics
- Increased Birthweight
- Increased Blood Glucose Levels
- Increased Bmi1 Levels in Intestinal Epithelial Cells
- Increased Body Mass
- Increased Body Mass Index
- Increased Body Weight
- Increased Body Weight Gain
- Increased Bone Marrow Myelopoiesis
- Increased Bone Mineral Density
- Increased Branched Chain Amino Acid Levels
- Increased Butyrate Levels
- Increased Butyrate-Producing Gut Bacteria
- Increased Butyric Acid Production
- Increased C-Peptide Secretion
- Increased C-Reactive Protein Level
- Increased C-Reactive Protein Levels
- Increased CD163+ Macrophage Density
- Increased CD68 to CD163 Ratio
- Increased CPT1 Protein Levels
- Increased Caloric Intake in Females
- Increased Carnosine Level
- Increased Catalase Activity
- Increased Cholesterol Excretion
- Increased Colonic SCFA Levels
- Increased Colonization by Beneficial Bacteria (Bifidobacterium animalis subsp. lactis BB-12)
- Increased Complement C3 Level
- Increased Conjugated Linoleic Acid Levels
- Increased Conjugated Linoleic Acid Production
- Increased Cortical Volumetric Bone Mineral Density
- Increased Cortisol Levels
- Increased Daily Sleep Duration
- Increased Daily Weight Gain
- Increased Distal Radius Bone Mineral Density
- Increased Diversity of Fecal Bifidobacterial Populations
- Increased ER Stress-Associated Proteins
- Increased Effectiveness of Oligosaccharide-Enriched Diet
- Increased Endometrial Thickness
- Increased Estradiol Level
- Increased Estrogen Level
- Increased Exercise Capacity
- Increased Exercise Endurance
- Increased FNDC5 Concentration
- Increased Fasting Insulin Level
- Increased Fat Oxidation
- Increased Fecal Acetate Concentration
- Increased Fecal Acetic Acid Concentration
- Increased Fecal Bifidobacteria Numbers
- Increased Fecal Bifidobacterium Count
- Increased Fecal Cholesterol Levels
- Increased Fecal Concentration of Propionic Acid
- Increased Fecal Lactobacillus Count
- Increased Fecal Lipid Excretion
- Increased Fecal Triglyceride Levels
- Increased Femoral Neck Bone Mineral Density
- Increased Free Fatty Acid Levels
- Increased GLP-1 Levels
- Increased Gastric Antral Length
- Increased General Morbidity
- Increased Glucagon-Like Peptide 1 Level
- Increased Glucose Metabolism Activation
- Increased Glucose Uptake by Cells
- Increased Glycine Level
- Increased Growth Rate
- Increased Gut Bifidobacteria
- Increased Gut Bifidobacterium Count
- Increased Gut Hormone Level
- Increased HDL Cholesterol Levels
- Increased Hepatic Lipid Metabolism Markers
- Increased High-Density Lipoprotein Cholesterol
- Increased High-Density Lipoprotein Levels
- Increased Hormone-Sensitive Lipase Activity
- Increased Human Milk Oligosaccharide Level
- Increased Hydroxy Fatty Acid Level
- Increased Hypothalamic Expression of Pro-inflammatory Markers
- Increased IL-6 Levels in Early Phase
- Increased IPA Levels
- Increased Indigenous Bifidobacterium Levels
- Increased Infant Weight
- Increased Inhibition of Lipid Oxidation
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Insulin Response
- Increased Insulin Secretion
- Increased Interleukin-6 Production in Macrophages
- Increased Intestinal Bifidobacterium Levels
- Increased Intestinal GLP-1 Levels
- Increased Lactobacillus plantarum Levels
- Increased Leptin Level
- Increased Leptin Levels
- Increased Leuconostoc Levels
- Increased Levels of Beneficial Metabolites
- Increased Lifespan
- Increased Lipid Oxidation
- Increased Lipolysis Activity
- Increased Litter Weight at Weaning
- Increased Longevity
- Increased Lower Body Weight
- Increased Lumbar Vertebra Bone Mineral Density
- Increased Maximal Incremental Cycling Capacity
- Increased Medium-Chain Acylcarnitines
- Increased Milk Component Concentrations
- Increased Muscle Fat Content
- Increased Nitric Oxide Metabolite Levels in Metabolic Syndrome Patients
- Increased Nitrogen Degradation Postprandially
- Increased Organ Weights
- Increased Oxidative Stress
- Increased Oxygen Consumption in White Adipose Tissue
- Increased PPAR-γ Activity
- Increased PUFA Levels in Breast Milk
- Increased Paraoxonase 1 Enzyme Activity
- Increased Peak Estradiol Concentration
- Increased Persistence of Beneficial Bacterial Species
- Increased Physical Activity
- Increased Plasma ApoA-V Levels
- Increased Plasma Haptoglobin Levels
- Increased Plasma Level
- Increased Polyphenol Level
- Increased Polyunsaturated Fatty Acids in Breast Meat
- Increased Polyunsaturated Fatty Acids in Milk
- Increased Postprandial Energy Expenditure
- Increased Prevotella Concentration
- Increased Pro-inflammatory Cytokine IL-6
- Increased Pro-inflammatory Cytokine Production
- Increased Propionate Production
- Increased Propionic Acid Production
- Increased Proportion of Bifidobacteria in Gut Microbiota
- Increased Proportion of Healthy Days
- Increased Protective Fecal Bifidobacteria
- Increased Reactive Oxygen Species Production
- Increased Relative Abundance of Beneficial Bacteria
- Increased Resistant Starch
- Increased Risk of Gastroesophageal Reflux Disease
- Increased SCFA Levels
- Increased SCFA Production
- Increased Sepsis
- Increased Serum Ferritin Level
- Increased Serum Free Fatty Acid Levels
- Increased Serum High-Molecular Weight Adiponectin
- Increased Serum Insulin Levels
- Increased Serum Metabolites to Combat Inflammation
- Increased Serum NAD+ Levels
- Increased Serum Triglycerides
- Increased Serum Tumor Necrosis Factor-α Levels
- Increased Short Chain Fatty Acid Profiles
- Increased Short Chain Fatty Acids
- Increased Short Chain Fatty Acids (SCFAs) Levels
- Increased Short-Chain Fatty Acid Levels
- Increased Short-Chain Fatty Acid Production
- Increased Short-Chain Fatty Acid-Producing Microbial Population
- Increased Short-Chain Fatty Acid-Producing Microbial Taxa
- Increased Short-Chain Fatty Acids (SCFAs) Contents
- Increased Short-Chain Fatty Acids Concentrations
- Increased Skeletal Muscle Mass Index
- Increased Solid Non-Fat Content
- Increased Superoxide Dismutase Level
- Increased Thermogenic Adipocyte Activity
- Increased Time to Exhaustion
- Increased Total Thiol Level
- Increased Triglyceride Level
- Increased Tumor Necrosis Factor-Alpha Levels
- Increased Uncoupling Protein 2 Level
- Increased Uric Acid Excretion
- Increased Vaginal Maturation Index
- Increased Valeric Acid Levels
- Increased Viable Cell Antioxidant Activity
- Increased Visceral Fat Mass
- Increased Voluntary Physical Activity
- Increased Weight
- Increased Weight Gain Post-Challenge
- Increased Weight Loss
- Increased Weight Z-Score in Infants
- Increased Weight in Normal Weight Children
- Increased Weight of Ham
- Increased c9t11 CLA Production in Adipose Tissue
- Increased β-Cell Area in Pancreatic Islets
- Induced Circadian Rhythm-Dependent Short-Chain Fatty Acid Production by Gut Microbiota
- Induction of Browning of White Adipose Tissue
- Influence on Infant Weight
- Influence on Metabolic Pathways
- Inhibited Lipid Oxidation
- Inhibited α-Amylase Activity
- Limited Weight Loss
- Maintained Body Weight
- Maintained Body Weight Post-Virus Infection
- Maintained Clinical Safety Parameters
- Maintained General Health
- Maintained Gut Microbiota Diversity
- Maintained High-Density Lipoprotein Levels
- Maintained Homeostasis
- Maintained Metabolic Homeostasis
- Maintained Normal Weight
- Maintained Physical Activity Level
- Maintained Physical Performance
- Maintained Weight
- Mature Gut Microbiota
- Mimicked Dietary Restriction Effects
- Modified Serum Metabolomic Pathways
- Modulated Diurnal Short-Chain Fatty Acid Production
- Modulated Endocannabinoid System
- Modulated Gastrointestinal Hormone Levels
- Modulated Gut Microbiome Composition
- Modulated Intestinal Microflora Composition
- Modulated PPAR/SREBP Pathway
- Multiple Health-Promoting Effects
- No Adverse Safety Findings
- No Adverse Weight or Intake Effects in Mice
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in Ectopic Fat Content
- No Change in Endogenous Bifidobacteria Species
- No Change in FSH Level
- No Change in Fecal Short-Chain Fatty Acid Concentration
- No Change in HDL Cholesterol
- No Change in High Density Lipoproteins
- No Change in Lipid Profile
- No Change in Metabolic Health
- No Change in Microbial Diversity
- No Change in Newborn Growth
- No Change in Overall Glucose Response
- No Change in Oxidative Stress Markers
- No Change in Serum Triglycerides
- No Clear Effect on Depression
- No Conclusive Efficacy
- No Increase in Plasma Endotoxin
- No Meaningful Change in IL-6
- No Reduction in Meat Cholesterol Levels
- No Significant Change in Body Weight or Systemic Inflammation
- No Significant Change in Endocannabinoid or Inflammatory Biomarkers
- No Significant Change in Growth Performance
- No Significant Change in Lean Body Mass
- No Significant Change in Muscle Mass
- No Significant Change in Triglyceride Levels
- No Significant Change in Tumor Necrosis Factor Alpha Levels
- No Significant Differences in Growth
- No Significant Effect on C-Reactive Protein Levels
- Normalization of Blood Biochemical Parameters
- Normalized Cortisol Levels
- Normalized Gut Metabolites
- Normalized Serum Lipid Levels
- Notable Improvement in Multiple Health Metrics
- Presence of Lactobacillus rhamnosus in Feces
- Prevented Increase in Serum CML Levels
- Prevention of Cardiovascular Diseases
- Prevention of Colorectal Cancer
- Prevention of Liver Steatosis
- Prevention of Nonalcoholic Fatty Liver Disease
- Prevention of Obesity Transition
- Prevention of Weight Gain
- Production of Probiotic Peptides
- Prolonged Gestation
- Promoted Weight Gain
- Reduced Abdominal Adiposity
- Reduced Abdominal Fat
- Reduced Abdominal Visceral Fat
- Reduced Abundance of Odoribacter
- Reduced Acetate to Propionate Ratio
- Reduced Adipocyte Diameter
- Reduced Adipocyte Hypertrophy
- Reduced Adipocyte Senescence
- Reduced Adipogenesis
- Reduced Adipose Cell Volume
- Reduced Adiposity
- Reduced Adipsin Level
- Reduced Adverse Physiometabolic Effects
- Reduced Age-Related Inflammation
- Reduced All-Cause Mortality
- Reduced Apelin Gene Expression
- Reduced Apolipoprotein B to A-1 Ratio
- Reduced Apolipoprotein B-100
- Reduced Arterial Stiffness
- Reduced Atherosclerosis
- Reduced Atherosclerosis Risk Factors
- Reduced Atrial Fibrillation Risk
- Reduced Bifidobacterium Counts
- Reduced Binge Eating Tendencies
- Reduced Blood Cholesterol
- Reduced Blood Glucose Elevation
- Reduced Blood Glucose Levels
- Reduced Blood Lipid Levels
- Reduced Blood Pressure
- Reduced Blood Pressure in Offspring
- Reduced Blood Serum Cholesterol
- Reduced Body Fat
- Reduced C-Reactive Protein Level
- Reduced Cancer Incidence
- Reduced Cancer Mortality
- Reduced Carboxymethyl Lysine
- Reduced Cardiovascular Disease
- Reduced Cardiovascular Disease Risk
- Reduced Cardiovascular Risk
- Reduced Cardiovascular Risk Profile
- Reduced Cerebrovascular Mortality
- Reduced Chocolate Craving
- Reduced Cholesterol Metabolism
- Reduced Circulating Endotoxin
- Reduced Colon Cancer Risk
- Reduced Common Cold Incidence
- Reduced Community Healthcare Costs
- Reduced Composite Score
- Reduced Conicity Index
- Reduced Coronary Heart Disease Risk
- Reduced Cost-Effectiveness in Reducing AAD
- Reduced Craving
- Reduced De Novo Lipogenesis
- Reduced Diabetes Incidence
- Reduced Diabetes Risk
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced Discontinuation Rates
- Reduced Disease Incidence
- Reduced Drug Concentration
- Reduced Dyslipidemia in Metabolic Syndrome
- Reduced Epididymal Adipose Tissue
- Reduced Epididymal Fat Mass
- Reduced Epididymal Fat Tissue Accumulation
- Reduced Exercise-Induced Glucose Levels
- Reduced Fasting Insulin Level
- Reduced Fat Gain
- Reduced Fatty Acid Synthesis
- Reduced Fecal Microbiota Diversity
- Reduced Flavonifractor Abundance
- Reduced Flavonoid Levels
- Reduced Food Cravings
- Reduced Free Androgen Index
- Reduced Free Fatty Acid Levels
- Reduced GIP
- Reduced GLP-1 Levels
- Reduced Gastrointestinal Cancer Risk
- Reduced Glutathione Redox Ratio
- Reduced Glycative Stress Marker Level
- Reduced Growth Hormone Level
- Reduced HDL Cholesterol Level
- Reduced HDL Levels
- Reduced HIF-1α Level
- Reduced HOMA-IR
- Reduced Harmful Lipid Levels
- Reduced Healthcare Costs
- Reduced Hepatic Fat Accumulation
- Reduced Hepatic Insulin Resistance
- Reduced Hepatic Lipogenesis
- Reduced Hepatic Triglyceride Levels
- Reduced High-Density Lipoprotein (HDL) Cholesterol
- Reduced High-Density Lipoprotein Cholesterol Level
- Reduced High-Sensitivity C-Reactive Protein
- Reduced High-Sensitivity C-Reactive Protein Level
- Reduced Hip Circumference
- Reduced Homeostatic Model Assessment for Insulin Resistance
- Reduced Hospital Readmission Risk
- Reduced Hydrogen Sulfide Level
- Reduced Hydroperoxide Levels
- Reduced Hyperglucagonemic Response
- Reduced Hypertension
- Reduced Incidence of Cardiovascular Disease
- Reduced Incidence of Colon Cancer
- Reduced Incidence of Liver Cancer
- Reduced Incidence of NAFLD
- Reduced Inflammation in Adipose Tissue
- Reduced Inflammatory Biomarker Level
- Reduced Insulin Response
- Reduced Insulin Sensitivity
- Reduced Insulin/IGF-1 Signaling
- Reduced Interleukin-6 Production
- Reduced Intracellular Triglyceride Levels
- Reduced Ischemic Heart Disease Mortality
- Reduced Kidney Stone Formation
- Reduced LDL Cholesterol
- Reduced Leg Adiposity
- Reduced Leptin Levels
- Reduced Lifespan
- Reduced Lipid Levels
- Reduced Lipid Oxidation
- Reduced Lipid Synthesis
- Reduced Liver Fat Accumulation
- Reduced Liver Fat Deposition
- Reduced Liver Triglycerides
- Reduced Low-Density Lipoprotein Level
- Reduced Luteinizing Hormone Level
- Reduced Lymphocytic Genome Damage
- Reduced Lysophosphatidylcholine Level
- Reduced Lysophosphatidylethanolamine 18:1 Level
- Reduced Macrophage Infiltration in Adipose Tissue
- Reduced Malondialdehyde Level
- Reduced Maternal Mortality
- Reduced Mean Blood Pressure
- Reduced Mesenteric Adipose Tissue Accumulation
- Reduced Metabolic Disease Risk
- Reduced Metabolic Disorders Incidence
- Reduced Metabolic Dysregulation
- Reduced Metabolic Endotoxemia
- Reduced Metabolic Function
- Reduced Metabolic Functions of Intestinal Microbiota
- Reduced Metabolic Inflammation
- Reduced Metabolic Lipopolysaccharide-Related Inflammation
- Reduced Metabolic Syndrome
- Reduced Monocyte Chemoattractant Protein-1 Level
- Reduced N-terminal Pro-B-type Natriuretic Peptide Level
- Reduced NAFLD Activity Score
- Reduced Non-Communicable Disease Risk
- Reduced Non-HDL Cholesterol
- Reduced Non-Infectious Complication Morbidity
- Reduced Obesity
- Reduced Obesity-Related Microbial Taxa
- Reduced Obesity-Related Taxa
- Reduced Oleic Acid-Induced Triglyceride Accumulation
- Reduced Oxidative Stress
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Marker
- Reduced PP4C Expression in Adipose Tissue
- Reduced Pancreatic Stress-Related Pathways
- Reduced Percentage of Bacteroidaceae in Gut Microbiota
- Reduced Perinatal Loss
- Reduced Physical Activity
- Reduced Physiological Impairments
- Reduced Plasma CRP Levels
- Reduced Plasma Cholesterol Levels
- Reduced Plasma Ghrelin Levels
- Reduced Plasma Leptin Levels
- Reduced Plasma Lipopolysaccharide Levels
- Reduced Plasma Malondialdehyde Levels
- Reduced Plasma Non-Esterified Fatty Acid Concentrations
- Reduced Plasma Triglycerides
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postpartum Hemorrhage Rate
- Reduced Postprandial Blood Glucose
- Reduced Postprandial Glycemia
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Pre-eclampsia
- Reduced Preoccupation with Food
- Reduced Pressure Ulcer Area
- Reduced Preterm Births
- Reduced Preterm Delivery
- Reduced Prevalence of Gestational Diabetes Mellitus
- Reduced Pro-brain Natriuretic Peptide Level
- Reduced Pro-inflammatory Biomarker Level
- Reduced Pro-inflammatory Cytokine Levels
- Reduced Protein Oxidation
- Reduced Recovery Time After Surgery
- Reduced Relative Abundance of Bacteroidales
- Reduced Relative Abundance of Coriobacteriaceae
- Reduced Risk of COVID-19 Progression
- Reduced Risk of Coronary Heart Disease
- Reduced Risk of Diabetes
- Reduced Risk of Preeclampsia
- Reduced SCD1 Activity
- Reduced Saturated Fatty Acids in Breast Meat
- Reduced Serum C-reactive Protein Levels
- Reduced Serum Cholesterol
- Reduced Serum Glycerophospholipid Levels
- Reduced Serum Inflammatory Cytokines
- Reduced Serum Inflammatory Factors
- Reduced Serum LDL Levels
- Reduced Serum Lipid Levels
- Reduced Serum MDA Concentrations
- Reduced Serum Plasminogen Activator Inhibitor-1
- Reduced Serum Somatostatin Levels
- Reduced Serum Triacylglycerols
- Reduced Serum Triglycerides
- Reduced Short-Chain Fatty Acids (SCFA)
- Reduced Small-for-Gestational-Age
- Reduced Sperm Motility
- Reduced Steatosis Score
- Reduced Stigmasterol Absorption
- Reduced Sugar Craving
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Surgical Intervention
- Reduced Symptoms Associated with High-Fat Diet
- Reduced Symptoms of High-Fat Diet Pathologies
- Reduced Systemic Endotoxemia at Rest
- Reduced Systemic Inflammatory Response
- Reduced TBARS Levels
- Reduced TMAO Level
- Reduced Total Blood Cholesterol
- Reduced Total Cholesterol Levels
- Reduced Total Cholesterol to HDL Cholesterol Ratio
- Reduced Total Glucagon-Like Peptide-1 Levels
- Reduced Total Human Milk Oligosaccharide Concentration
- Reduced Total Testosterone Level
- Reduced Triglycerides
- Reduced Trimethylamine N-oxide Levels
- Reduced Type 2 Diabetes Symptoms
- Reduced Very Low-Density Lipoprotein
- Reduced Visceral Fat
- Reduced Visceral Fat Accumulation
- Reduced Visceral Fat Area
- Reduced Visceral Fat Mass
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Reduced Waist-to-Hip Ratio
- Reduced hsCRP Level
- Reduced γ-Proteobacteria Levels in Human Milk-Fed Infants
- Regulated Blood Lipid Levels
- Regulated Blood Pressure
- Regulated Body Weight
- Regulated Circadian-Metabolic Axis
- Regulated Gut Microbiota
- Regulated Gut Microbiota Metabolic Function
- Regulated Lipid Metabolism
- Regulated Lipid Metabolism in Epididymal Fat Pads
- Regulated Metabolic Function
- Regulated Tryptophan Metabolism
- Remission of Metabolic Syndrome
- Remodeled Intestinal Microbiota
- Restoration of Homeostasis
- Restored Gut Microbiota Diversity
- Restored HDL Levels
- Restored Lipid Metabolism
- Restored Microbial Diversity
- Restored Short-Chain Fatty Acid Levels
- Reversed HFD-Induced Bifidobacterium Depletion
- Reversed Microbiome Metabolic Changes
- Safe Administration
- Safe for Chronic Consumption
- Safety of Consumption
- Stabilized Visceral Fat Area
- Stable Appetite Parameters
- Stable Body Mass
- Stable Body Weight
- Stable Body Weight Post-RSV Infection
- Stable Body-Mass Index (BMI)
- Stable HDL Cholesterol Levels
- Stable High-Density Lipoprotein Cholesterol Level
- Stable Organ Weight
- Stable Weight
- Suppressed PPAR/SREBP Pathway Gene Activity
- Unchanged Body Composition
- Unchanged Insulin Sensitivity
- Unchanged Plasma Lipid Levels
- Unchanged Waist-to-Hip Ratio
- Weight Gain Consistency